Inflarx GmbH

Allemagne


Commandez votre montre hebdomadaire Inflarx GmbH
Quantité totale PI 44
Rang # Quantité totale PI 32 543
Note d'activité PI 2,4/5.0    31
Rang # Activité PI 24 575
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

16 3
6 3
9 4
3
 
Dernier brevet 2025 - Fused piperidinyl bicyclic and r...
Premier brevet 2010 - Anti-c5a binding antibodies with...
Dernière marque 2024 - GOHIBIC
Première marque 2018 - InflaRx

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Fused piperidinyl bicyclic and related compounds for use in the treatment of diseases. The presen...
Invention Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor. The present inve...
P/S Pharmaceuticals, medical and veterinary preparations targeting acute and chronic inflammation.
2023 Invention Treatment of pneumonia and ards with inhibitors of c5a and il-6 activity. The present invention r...
2022 P/S Pharmaceuticals and medical preparations targeting acute and chronic inflammation
P/S Pharmaceuticals, medical and veterinary preparations targeting acute and chronic inflammation; an...
P/S [ Pharmaceuticals, medical and veterinary preparations targeting acute and chronic inflammation; ...
P/S Pharmaceuticals, medical and veterinary preparations; pharmaceuticals, medical and veterinary pr...
P/S Pharmaceuticals, medical and veterinary preparations targeting acute and chronic inflammation, na...
P/S Antibodies, specifically monoclonal antibodies, namely monoclonal antibodies targeting acute and ...
P/S Pharmaceuticals, medical and veterinary preparations; Pharmaceuticals, medical and veterinary pre...
2021 Invention Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor. The present inven...
Invention Humanized anti-c5a antibodies. The present invention relates to antibodies that specifically bin...
Invention Humanized anti-c5a antibodies. The present invention relates to antibodies that specifically bind...
2020 Invention Treatment of inflammatory diseases with inhibitors of c5a activity. a activity and their use in t...
Invention Inhibitors of c5a for the treatment of corona virus infection. The present invention relates to ...
Invention Inhibitors of c5a for the treatment of corona virus infection. The present invention relates to a...
Invention Substituted-piperidinyl compounds for treatment of diseases modulated by c5a receptor. The presen...
2019 Invention Treatment of inflammatory diseases with inhibitors of c5a activity. The present invention relates...
Invention Inhibitors of c5a for the treatment of viral pneumonia. The present invention relates to inhibito...
2018 P/S Pharmaceuticals and veterinary preparations.
2016 Invention Anti-c5a binding moieties with high blocking activity. The present invention relates to binding m...
2010 Invention Anti-c5a binding antibodies with high block activity. The present invention relates to binding mo...